Changes to Patent Examination Guidelines Concerning Computer- Implemented Invention in Vietnam Effective April 2022

           Computer programs are generally known as a set of instructions expressed in the form of source codes, and when being executed by a computer device, are capable of performing a task or achieving a result. In Vietnam, computer programs are recognized as literary works and are protected under the copyright regime. Therefore, computer programs […]

Singapore Patent Office Accepts International Applications filed in Chinese

The Intellectual Property Office of Singapore (“IPOS”), in its capacity as a receiving Office, International Search Authority (“ISA”), and International Preliminary Examination Authority (“IPEA”) under the Patent Cooperation Treaty, accepts international applications filed in the Chinese language. The Patents Rules in Singapore were amended on 1 January 2017 to allow Chinese as a language for […]

IPOS Extended Its Patent Acceleration Initiatives under ASPEC AIM Programme and PPH Programme with China

The Intellectual Property Office of Singapore (IPOS) has recently extended its two pilot patent acceleration programmes such as the ASPEC Acceleration for Industry 4.0 Infrastructure and Manufacturing Pilot (ASPEC AIM) Programme until 26 August 2023, and the Patent Prosecution Highway (PPH) agreement with the China National Intellectual Property Administration (CNIPA) until 31 August 2026, in […]

Updates on Singapore patent practice

Following a series of public consultation and discussions, the Intellectual Property Office of Singapore (IPOS) has confirmed that they will launch a formal procedure for the submission of “third party observations” under which members of the public will be able notify IPOS of information that might be of relevance to the patentability of an invention […]

TRIPS waiver in light of the COVID-19 pandemic in Philippines

The World Health Organization’s – Trade-Related Aspects of Intellectual Property (TRIPS) is a global multilateral agreement on intellectual property (IP).1 The TRIPS Waiver refers to the October 2020 proposal by India and South Africa for a brief waiver of intellectual property rights that protect inventions that are required to prevent, contain or treat COVID-19. They […]

Favipiravir: Patent rejection in Thailand

Favipiravir (or T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is a broad-spectrum antiviral drug used in the treatment of multiple diseases, and is the first drug approved by countries around the world as an emergency option for Covid-19 cases. Thailand’s Department of Intellectual Property (DIP) has since rejected a Thai patent application filed under the compulsory license system for a […]

Vietnam – Circular No. 6959/TB-SHTT to temporarily ease the stringent signatory requirement by Circular No. 13822/TB-SHTT

The Intellectual Property Office of Vietnam (NOIP) has released a new circular, Circular No. 6959/TB-SHTT (“Circular 6959”) in order to temporarily ease the strict requirements in relation to the signatory requirements of the formal documents in relation to patent applications such as powers of attorney, deeds of assignment, etc. submitted to the NOIP previously imposed […]

A second-round victory for brand drug owners against generics who fail to declare relevant patents under Singapore’s patent linkage regime

Proprietors of brand-name drugs may heave another sigh of relief as the Singapore Court of Appeal in Zyfas Medical Co (Sued as a firm) v. Millennium Pharmaceuticals, Inc [2020] SGCA 84 re-affirmed its holding in Millennium Pharmaceuticals, Inc v. Drug Houses of Australia Pte Ltd [2019] SGCA 31 (the DHA decision) rejecting an overly-restrictive interpretation […]